| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |